Loss or partial loss of CD20 expression was seen in 13/17 DLBCL/HGBCL‐MYC/BCL2, 2/3 HGBCL‐NOS, and 2/2 unclassified, albeit not in DLBCL‐NOS. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.